With continuing changes in where HCPs are going for information, Medical Affairs has to be flexible and ensure our content is reaching our audiences. This often requires approval of a novel channel for Medical Affairs, but gaining internal compliance approvals can be challenging. This webinar will focus on practical ways to optimize your partnerships with compliance to ensure successful approval and launch of novel channels.
Medical Affairs professionals want to share Real-World Evidence (RWE) about drug products with payers, patient advocates and others, but communications about drug products are highly regulated. Federal laws, including FDAMA Section 114, FDA guidance materials and FDA enforcement actions all provide insight into the types of communications FDA will and will not accept. This presentation will provide insights into the types of communications that FDA has indicated are or are not permissible, and the uncertainties that still remain.
How do leaders make their way to Medical Safety & Pharmacovigilance? The routes are diverse but one constant remains true: They are extremely committed to being an independent voice that amplifies their organization’s commitment to Patient Centricity.
This podcast, part two of a two-part series, discusses practical tips on how to incorporate cybersecurity into your own practices and devices.Â
This MAPS podcast details what medical device cybersecurity is and why you should care.
At the end of the webinar, participants will have a better ​understanding of:​
• Potential hurdles of the MLR review process​
• Roles, responsibilities and function alignment ​
• Our changing MLR environment and possible solutions
At the end of the webinar, participants will have a better understanding of:
– Enforcement trends relating to speaker programs
– Key risks associated with the shift from in-person to virtual activities due to the pandemic
– Compliance considerations for conducting promotional and educational activities virtually
By participating in this Webinar, attendees will be able to understand the importance of E&C in Medical Affairs and the amount of topics that this can cover
In this webinar, we explore two scenarios that can open Medical Affairs up to censure. Scenario one explores participation of commercial team members in Medical Advisory Boards and scenario two looks at the implications of a commercial team member requesting a medical team member to participate in a thought leader meeting.
By participating in this eCademy Webinar, attendees will be better able to: